Childhood cancer survivors face risks from a variety of late effects, including cardiac events, second cancers, and late mortality. The aim of the pan-European PanCare Childhood and Adolescent Cancer Survivor Care and Follow-Up Studies (PanCareSurFup) Consortium was to collect data on incidence and risk factors for these late effects among childhood cancer survivors in Europe. This paper describes the methodology of the data collection for the overall PanCareSurFup cohort and the outcome-related cohorts. In PanCareSurFup 13 data providers from 12 countries delivered data to the data centre in Mainz. Data providers used a single variable list that covered all three outcomes. After validity and plausibility checks data was provided to the out...
Introduction: Long-term survival after childhood cancer often comes at the expense of late, adverse ...
Late mortality of European five-year survivors of childhood or adolescent cancer has dropped over th...
Objective: In this report, we determine the cumulative incidence of symptomatic cardiac ischaemia an...
Childhood cancer survivors face risks from a variety of late effects, including cardiac events, seco...
Background: Second malignant neoplasms and cardiotoxicity are among the most serious and frequent ad...
Background: Second malignant neoplasms and cardiotoxicity are among the most serious and frequent ad...
BACKGROUND Second malignant neoplasms and cardiotoxicity are among the most serious and frequent ...
With the advent of multimodality therapy, the overall five-year survival rate from childhood cancer ...
With the advent of multimodality therapy, the overall five-year survival rate from childhood cancer ...
BACKGROUND AND AIM:Childhood cancer survivors are at high risk of long-term adverse effects of cance...
Background and Aim Childhood cancer survivors are at high risk of long-term adverse effects of cance...
Survival after childhood cancer has improved substantially over recent decades. Although cancer in c...
Background and Aim Childhood cancer survivors are at high risk of long-term adverse effects of cance...
Background and AimChildhood cancer survivors are at high risk of long-term adverse effects of cancer...
Long-term survival after childhood cancer often comes at the expense of late, adverse health conditi...
Introduction: Long-term survival after childhood cancer often comes at the expense of late, adverse ...
Late mortality of European five-year survivors of childhood or adolescent cancer has dropped over th...
Objective: In this report, we determine the cumulative incidence of symptomatic cardiac ischaemia an...
Childhood cancer survivors face risks from a variety of late effects, including cardiac events, seco...
Background: Second malignant neoplasms and cardiotoxicity are among the most serious and frequent ad...
Background: Second malignant neoplasms and cardiotoxicity are among the most serious and frequent ad...
BACKGROUND Second malignant neoplasms and cardiotoxicity are among the most serious and frequent ...
With the advent of multimodality therapy, the overall five-year survival rate from childhood cancer ...
With the advent of multimodality therapy, the overall five-year survival rate from childhood cancer ...
BACKGROUND AND AIM:Childhood cancer survivors are at high risk of long-term adverse effects of cance...
Background and Aim Childhood cancer survivors are at high risk of long-term adverse effects of cance...
Survival after childhood cancer has improved substantially over recent decades. Although cancer in c...
Background and Aim Childhood cancer survivors are at high risk of long-term adverse effects of cance...
Background and AimChildhood cancer survivors are at high risk of long-term adverse effects of cancer...
Long-term survival after childhood cancer often comes at the expense of late, adverse health conditi...
Introduction: Long-term survival after childhood cancer often comes at the expense of late, adverse ...
Late mortality of European five-year survivors of childhood or adolescent cancer has dropped over th...
Objective: In this report, we determine the cumulative incidence of symptomatic cardiac ischaemia an...